Skip to main content
. 2022 Mar 11;11(6):1538. doi: 10.3390/jcm11061538

Table 3.

CTA findings, intervention, and outcome data of the patients.

All Patients Patients with Pneumonia Patients without Pneumonia
n = 17 n = 13 n = 4
Patients with unilateral occlusions, n (%) 1 (5.9) 1 (5.9) 0
Patients with bilateral occlusions, n (%) 16 (94.1) 12 (70.6) 4 (23.5)
Occlusions by stenosis degree, n (%)
Subocclusions 126 (62.1) 100 (49.3) 26 (12.8)
Total occlusions (100%) 77 (37.9) 59 (29.1) 18 (8.8)
Thrombus length, n (%) b
Short segment occlusions (<10 cm) 36 (32.4) 34 (30.6) 2 (1.8)
Intermediate segment occlusions (10–20 cm) 21 (18.9) 13 (11.7) 8 (7.2)
Long segment occlusions (>20 cm) 54 (48.7) 39 (35.1) 15 (13.5)
Anticoagulant therapy before surgery, n (%) a
Prophylaxis dose 14 (82.4) 11 (64.7) 3 (17.6)
Therapeutic dose 3 (17.6) 2 (11.8) 1 (5.9)
Intervention, n (%)
Conservative (LMWH) 2 (11.8) 1 (5.9) 1 (5.9)
Thrombectomy 9 (52.9) 6 (35.3) 3 (17.6)
Amputation 6 (35.3) 6 (35.3) 0
Outcome, n (%)
Death 10 (58.8) 10 (58.8) 0
Discharge 7 (41.2) 3 (17.6) 4 (23.5)
CXR chest X-ray, LMWH low molecular weight heparin.

a Number of affected patients divided by the total patient number (n = 17). b Number of observations is divided by the total count of occlusions (n = 203) or thrombus (n = 111).